J Korean Burn Soc.  2019 Jun;22(1):10-14. 10.0000/jkbs.2019.22.1.10.

The Clinical Investigation Study of Pancreatitis Developed in Burn Patients

Affiliations
  • 1Department of Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
  • 2Department of Burn Surgery, Hangang Sacred Heart Hospital, Hallym University, Seoul, Korea. chun0414@hallym.or.kr

Abstract

PURPOSE
To find progression and prognosis of pancreatitis developed in massive burn patients through retrospective analysis.
METHODS
A retrospective study was conducted on 32 patients with abnormal increase of serum lipase level among 2523 acute burn patients admitted to our burn center from January 1, 2017 to June 30, 2018. Pancreatitis in this study was defined as a serum lipase concentration level that is higher than 180 IU/L which is three times more than the normal level (less than 60 IU/L). In this study, a retrospective analysis was performed on patients with serum lipase level higher than 300 IU/L to better understand causality of burns and pancreatitis.
RESULTS
32 patients (1.27%) had serum lipase level higher than 180 IU/L among 2523 acute burn subjects. And 13 patients (0.52%) of these 32 patients had serum lipase level elevated more than 300 IU/L. The study indicated serum lipase level was increased around 7 days after the injury. It returned to normal level early as after 1 to 2 weeks and late as after 4 to 6 weeks of injury. The serum amylase level was increased as similar modality as to the serum lipase level increase. The serum bilirubin, AST, ALT, LD, and GGT were also observed to be elevated when serum lipase was more than 1000 IU/L.
CONCLUSION
The pancreatitis developed in burn patients are mostly as mild symptom. It could due to the ischemic injury and can easily be treated by a temporary fasting, TPN, and Gabexate intravenous injection.

Keyword

Pancreatitis; Burns
Full Text Links
  • JKBS
Share
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr